NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in NovaBridge Biosciences as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 75
- −21 vs. Q2 2022
- Shares held
- 30.8M
- −7.45M (−19.5%) vs. Q2 2022
- Total value
- $123.3M
- −$307.0M (−71.3%) vs. Q2 2022
- New holders
- 11
- 21 more added
- Sold out
- 32
- 28 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 49 | $48.1M |
| Q1 2026 | 48 | $72.1M |
| Q4 2025 | 57 | $132.1M |
| Q3 2025 | 42 | $112.3M |
| Q2 2025 | 32 | $22.7M |
| Q1 2025 | 29 | $7.41M |
| Q4 2024 | 28 | $10.1M |
| Q3 2024 | 28 | $17.6M |
| Q2 2024 | 38 | $25.3M |
| Q1 2024 | 39 | $22.7M |
| Q4 2023 | 44 | $23.5M |
| Q3 2023 | 47 | $20.1M |
| Q2 2023 | 48 | $55.9M |
| Q1 2023 | 53 | $71.6M |
| Q4 2022 | 69 | $103.9M |
| Q3 2022 | 75 | $123.3M |
| Q2 2022 | 97 | $430.3M |
| Q1 2022 | 120 | $654.5M |
| Q4 2021 | 132 | $1.85B |
| Q3 2021 | 145 | $2.61B |
| Q2 2021 | 136 | $2.38B |
| Q1 2021 | 80 | $1.13B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding NovaBridge Biosciences; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −2,700−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −2,400−100.0% | Sold out |
| Sage Partners Ltd | 0 | $0 | 0.00% | −2,054−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −404−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −137−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Exane Derivatives | – | – | – | – | Not filed |